Simon Sturge Moon Lake Immunotherapeutics (MLTX) insider trading activity
Simon Sturge is Director of MoonLake Immunotherapeutics. Currently has a direct ownership of 171,980 shares of MLTX, which is worth approximately $8.95 Million. The most recent transaction as insider was on Oct 04, 2024, when has been sold 171,000 shares (Class A ordinary shares, par value $0.0001 per share) at a price of $53.72 per share, resulting in proceeds of $9,186,120. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
172K
Infinity%
3M change
Infinity%
12M change
Total Value Held
$8.95 Million
Simon Sturge Transaction History
SS
Simon Sturge
Director
Zug, V8